Company profile
North American Cannabis Holdings, Inc.
OTC: USMJ · Healthcare · Drug Manufacturers - Specialty & Generic
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 42
v0.1 · 5/100 weight · pillars only
↑ listing tenure, filing timeliness · ↓ Piotroski F, workforce scale
Methodology →Revenue TTM
$129.5k
Rev growth YoY (TTM)
-22.4%
Net income (FY)
—
Employees
2
as of 2026-08-25
Market cap
$1.4M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is North American Cannabis Holdings, Inc.’s financial profile?
North American Cannabis Holdings, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Kelyniam Global, Inc.——Stemsation International, Inc.——Somatic Systems, Inc.——Mid-Atlantic Home Health Network, Inc.——CDT Equity Inc.——Dermata Therapeutics, Inc.——Neighbors
Dallas →Key facts
CEOSteven Rash
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersDallas, TX
ExchangeOTC: USMJ
Employees2
IPO date1998-11-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.